[Performance of lipid profile request between public and private sectors]. 2008

Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
Programa de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Pelotas, RS, Brasil. lduro2002@yahoo.com.br

OBJECTIVE To evaluate the performance of lipid profile screening according to the mode of financing of medical appointments - public or private. METHODS A population-based cross-sectional study was carried out with a multi-stage sampling strategy. The study included 3,136 adults (>or=20 years old) from the city of Pelotas, Southern Brazil, in 2006. The following indicators were calculated: coverage (proportion of screened individuals among those meeting screening criteria), focus (proportion of individuals meeting screening criteria among those who were tested), screening errors (tests in individuals not meeting screening criteria - overscreening - and no screening of individuals meeting the screening criteria - underscreening), and screening ratio (ratio between number of individuals who met screening criteria and the number who failed to meet screening criteria among all individuals tested). Bivariate analyses were performed using Chi-squared tests. 95% confidence intervals (95% CI) were calculated for all parameters assessed. RESULTS General coverage was 73.0% (95%CI: 70.8;75.2), and focus was 67.2% (95% CI: 64.7;69.3). In the public sector, compared to the private/health plan sector, coverage was lower (65.2% vs. 82.2%; p<0.001), focus was higher (74.7% vs. 62.3%; p<0.001), overscreening was lower (33.1% vs. 56.4%; p<0.0001), and underscreening was higher (34.8% vs. 17.8%; p<0.0001). Screening ratio was higher in the public (1.97) than in the private sector (1.46). CONCLUSIONS The evaluation of adequacy of lipid profile requests among the population can provide important information regarding the following of protocols for screening and following-up dyslipidemias in different healthcare systems and, within a same system, between different modes of financing. Evaluations of this type provide an opportunity to diagnose inequalities and plan efforts to ensure greater equity of care.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009313 National Health Programs Components of a national health care system which administer specific services, e.g., national health insurance. National Health Insurance, Non-U.S.,Health Services, National,National Health Insurance,National Health Insurance, Non U.S.,National Health Services,Services, National Health,Health Insurance, National,Health Program, National,Health Programs, National,Health Service, National,Insurance, National Health,National Health Program,National Health Service,Program, National Health,Programs, National Health,Service, National Health
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003695 Delivery of Health Care The concept concerned with all aspects of providing and distributing health services to a patient population. Delivery of Dental Care,Health Care,Health Care Delivery,Health Care Systems,Community-Based Distribution,Contraceptive Distribution,Delivery of Healthcare,Dental Care Delivery,Distribution, Non-Clinical,Distribution, Nonclinical,Distributional Activities,Healthcare,Healthcare Delivery,Healthcare Systems,Non-Clinical Distribution,Nonclinical Distribution,Activities, Distributional,Activity, Distributional,Care, Health,Community Based Distribution,Community-Based Distributions,Contraceptive Distributions,Deliveries, Healthcare,Delivery, Dental Care,Delivery, Health Care,Delivery, Healthcare,Distribution, Community-Based,Distribution, Contraceptive,Distribution, Non Clinical,Distributional Activity,Distributions, Community-Based,Distributions, Contraceptive,Distributions, Non-Clinical,Distributions, Nonclinical,Health Care System,Healthcare Deliveries,Healthcare System,Non Clinical Distribution,Non-Clinical Distributions,Nonclinical Distributions,System, Health Care,System, Healthcare,Systems, Health Care,Systems, Healthcare
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
February 2012, Human vaccines & immunotherapeutics,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
May 1998, Nature medicine,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
October 2011, Arquivos brasileiros de cardiologia,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
January 1978, Human resource management,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
June 2008, Nature biotechnology,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
March 2021, Health policy (Amsterdam, Netherlands),
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
March 2001, Nature,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
July 2001, Nature biotechnology,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
June 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Luciano N Duro, and Maria Cecília Assunção, and Juvenal Soares Dias da Costa, and Iná S Santos
January 2015, PloS one,
Copied contents to your clipboard!